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Summary The immWlosuppressive drug, FK 506, 
increased the regeneration response that 
follows 40% and 70% hepatectomy in rats. The effect was 
similar to that obtained with cyclosporin. 
INTRODUCTION 
AZATHIOPRINE and adrenocortical steroids, which were 
the most widely used maintenance immWlosuppressive 
agents Wltil the introduction of cyclosporin, depress the 
regeneration response after partial hepatectomy.'" In 
contrast, cyclosporin augments hepatic regeneration in 
rats3-5 and in dogs6 with an Eck fistula, which allows 
hepatocyte replication and hypertrophy to be studied 
separately.' In dogs with an Eck fistula cyclosporin has the 
hepatotrophic (liver supporting) properties that have been 
associated with anabolic hormones such as insulin and 
growth factors.'·8 However, it is Wlknown whether the 
hepatotrophic qualities of cyclosporin are the result of its 
immWlosuppressive action. To clarify this issue, we have 
studied the effect on rat liver regeneration of FK 506, an 
immWlosuppressive macrolide obtained from cultures of 
Streptomyces tsukubaensis" FK 506 is more potent than 
cyclosporin on a molar basis. 
METHODS 
Adult male inbred Fisher 344 rats weighing 180-200 g were 
purchased from Hilltop Lab Animals Inc (Scottdale, 
Pennsylvania). The arumals were given standard rat laboratory diet 
and water ad libitum in a temperature and light controlled room 
(light 07~ 1930). The rats were assigned to groups and treated for 
4 days as controls or with cyc1osporin or FK 506 (table I). On the 
fourth day, between 0900 and 1030, the rats in groups 5-10 had a 
standard 40% or 70% hepatectomy under light ether anaesthesia. 
Animals in groups 3 and 4 had sham operations in which the liver 
TABLE I-REGIMENS 
Cyclosporin FK506 
Group Route (mg/kg) (mg/kg) Vehicle~ Hepatectomy 
I (n=5) 1M 
· . 
.. Saline .. 
2 (n=5) 1M 
· . 
1 Saline .. 
3 (n= 10) 1M .. .. Saline Sham 
4(n= 10) 1M .. I Saline Sham 
5 (n=8) 1M · . .. Saline 40% 
6 (n=8) 1M 
· . 
I Saline 400/;) 
7 (n=20) PO · . .. Olive oil 70% 
8 (n=20) 1M .. .. Saline 70% 
9 (n= IS) PO 10 .. Olive oil 70% 
10 (n = 15) 1M 
· . 
I Saline 70% 
~250 III saline or 200 1'1 olive oil. 1M = intramuscular, PO = oral. 
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TABLE I1-EFFECr OF CYCLOSPORIN AND FK 506 ON RAT LIVER 
REGENERATION (MEAN, SE) 
3H-thymidine incorporation Proportion of hepatocyte, 
Group ( x 10' cpm/mg DNA) in mitosis (%) 
1 3-3 (0·4) 1·6 (0·1) 
2 3·2 (03) 1·7 (0·1) 
3 4·9 (0·5) 6·8 (0·6)~ 
4 10·5 (0·8)~ 9·5 (0·5):1 
'j 12·5 (13) 
6 32·4 (S·2)t 
7 138·1 (13·1) 31·0 (2·0) 
8 130·0 (9·2) 29·0 (2·S) 
9 179·0 (14·0)t 44·0 (2·1)t 
10 242·0 (28·0)* 59·0 (3·0)§ 
Srudent's t test: ~p<0·005 vs groups 1,2, and 3. tp<O·OOl vs group 5. 
tp<0·05 vs group 7. §p<O·OOl vs group 8. ~lp<O·Ol vs groups I and 2. 
Ip < 0·05 vs groups 1 and 2. 
was manipulated at laparotomy. Food and drink were allowed 
immediately. Parenteral fluid and electrolyte support were not 
required. 
24 h after the hepatectomies, 185 x 10" Bq 'H-thymidine was 
administered to all rats by intraperitoneal injection. The rats, 
including groups 1 and 2, were killed 2 h later by guillotine. 
Extraction and purification of hepatic DNA were done with the 
method of Ove et alto and DNA content was measured with calf 
thymus DNA (Sigma) as standard." Specimens from each liver 
were prepared for histological examination with haematoxylin-
eosin and the proportion ofhepatocytes in mitosis was counted. 
All results are means and SE. 
RESULTS 
As expected DNA synthesis and the proportion of 
hepatocytes in mitosis were increased in rats with a 40% 
or 70% hepatectomy that were not given cyclosporin or 
FK 506 (groups 5, 7, and 8; table II). After pretreatment for 
4 days before hepatectomy with intramuscular FK 506 
(groups 2, 4, and 10) or oral cyclosporin (group 9), 
regeneration was significantly augmented compared with 
controls. The effect was greater with FK 506 than with 
cyclosporin (group 10 compared with group 9). FK 506 did 
not increase resting hepatocyte mitosis or DNA synthesis. 
These indices were slightly increased in rats submitted to 
sham operation. When FK 506 was added to the sham 
operation group, hepatocyte mitosis and DNA synthesis 
were further and significantly increased. 
DISCUSSION 
We fOWld that the proliferative component of rat liver 
regeneration was augmented by FK 506, as has been 
demonstrated previously for cyclosporin. ~s FK 506 1 mg/kg 
intramuscularly was more effective than cyclosporin 
10 mg/kg orally. However, the different doses and routes of 
administration make this comparison inconclusive. 
The mechanism of this effect is Wlknown. Possibly these 
two agents, which have different structures, have effects on 
growth control that are related to their immWlosuppressive 
action. That is, the events of regeneration may be modulated 
immWlologically, which has been hinted at previously. 12-14 
For example, DNA synthesis increases in lymphoid tissues 
after hepatectomyr the serum of rats after partial 
hepatectomy can stimulate lymphoid proliferation,t4 and 
splenectomy enhances regeneration. 15 In contrast regener-
ation is depressed after non-specific immWlosuppression 
with azathioprine I and steroids.2 The augmentation of 
regeneration by cyclosporin is well established.3-5,13 
1,> ... 
· .• 
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Both FK 506 and cyclopsorin specifically inhibit the 
T-cell response,··16 which could explain why both these 
agents promote increased regeneration. The dominant 
effect of specific components of the immune system could be 
to restrict cellular growth in general, not just that involved in 
liver regeneration. A "braking" effect of the immune system 
may be dependent on T-cell function and apply to normal as 
well as to abnormal or replicating cells. 
How does the regnerating liver know when to stop 
regrowth at the proper size and time? Endogenous 
inhibitory factors or hormones are possible mediators.7 .B 
Research on immunosuppression for transplantation and 
investigations of hepatic regeneration could lead to a better 
understanding of the interaction betw~en growth control 
and immune function. Non-immune mechanisms may be 
involved. Both cyclosporin andFK 506 inhibit interleukin 2 
production and binding. '.16 By inhibition of this second 
signal, both drugs could interrupt the secretion of liver 
regulatory factors not directly connected with the immune 
system. 
This study was supponed by research grants from the Veterans 
Administration and project grant DK 29961 from the National Institutes of 
Health, Betbesda, Maryland. 
Correspondence should be addressed to T. E. S., Depanment of Surgery, 
Falk Clinic, 3601 Fifth Avenue, Pinsburgh, Pennsylvania 15213, USA. 
Reviews of Books 
Handbook of Neurological Investigations in 
Children 
J. B. P. Stephenson and Mary D. King. London: Butterworth 
1989. Pp 244. £25. ISBN 0-723612951. 
MY'heart sank when I removed this from The Lancet's 
jiffy bag: why should two distinguished neurologists 
demean themselves by joining the investigational recipe-
book business? My misgivings about this approach stem 
from the differences between general and specialist 
paediatric practice. When assessing a child 01: infant with 
fits, faints, and funny turns I (a generalist) usually adopt the 
pooh-pooh approach of Sir Robert Hutchison. The 
opposite attitude he described as wind-upper, and that is 
how I felt after.an intellectual mauling at the hands of,Dr 
Stephenson and Dr King, who ahpost persuaded me that 
my management of children. with possible neurological 
disorders is cav~lier if not negligent. There is a serious point 
here. Paediatrics is. tackling medical audit seriously, with 
proposals for protocols for investigation of certain 
conditions. If the. compilation of these protocols becomes 
the exclusive responsibility of specialists there is risk of 
biasing that investigation towards fmding the uncommon 
patient with some rare condition or complication dealt with 
by those specialists. The penalty will be costly 
overinvestigation of many other children who present with a 
symptom that might be a feature of the recherche but usually 
is not. Herein lies the danger of unselective clinical use of 
recipe books that are less concerned with what symptoms to 
investigate than with how best to investigate certain 
symptoms: the medical audit of outpatient general medicine 
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of childhood should be directed towards symptoms rather 
than conditions. 
Notwithstanding these strictures the general physician 
will learn much from this volume. An important 
responsibility of the specialist is to help generalist colleagues 
to manage their patients better; this book amply fulfils such a 
requirement and thus answers my opening question. The 
text is split into two sections, the first dealing with ttlllts and 
the second with presenting complaints and their 
investigations. The introduction and appendix contain 
salutary comments on the philosophy and value of tests and 
this wise thinking predominates. What questions are you 
trying to answer by doing this investigation? What are the 
chances that the test will answer it? Might there. be a better 
alternative? The risk of spraying tests at the abnormal child 
is emphasised; parents may become impatient with the 
methodical sequential approach but it is rarely in the child's 
interests to cut corners and the doctor's job is to resist 
pressures for speedy and possibly inaccurate diagnosis. 
Perhaps the ,greatest weakness is the lack of a chapter·on 
history-taking since skill and experience here will generally 
lead to economical investigation-but the authors would 
probably say tnat their brief was to discuss the management 
of a child who haS been sifted by such a' discriminating 
process. If so, they are to be congratulated on a well written 
and attractively presented book. It is not· for use by the 
uncritical, and free-ranging house physician (lest he 01; she 
bankrupt the hospital) but more for the specialist trainee or a 
discerning general paediatric physician faced with a 
challenging case and who is unable to contact the paediatric 
neurologist. . 
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